UGT1A1 genotype as an indicator of neutropenia for FOLFOXIRI with bevacizumab in patients with mCRC (QUATTRO study)

被引：0

作者：

Oki, Eiji ^{[1
]}

Yoshino, Takayuki ^{[2
]}

Muro, Kei ^{[3
]}

Emi, Yasunori ^{[4
]}

Tsuji, Akihito ^{[5
]}

Yamasaki, Kentaro ^{[10
]}

Yamanaka, Takeharu ^{[7
]}

Sakisaka, Hideki ^{[6
]}

Kato, Takeshi ^{[8
]}

Kanazawa, Akiyoshi ^{[9
]}

机构：

[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan

[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[3] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[4] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan

[5] Kagawa Univ, Takamatsu, Kagawa, Japan

[6] Osaka Minato Cent Hosp, Osaka, Japan

[7] Yokohama City Univ, Yokohama, Kanagawa, Japan

[8] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan

[9] Kitano Hosp, Osaka, Japan

[10] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ISY-17-2

引用

页数：1

共 50 条

[11] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters
Ichikawa, Wataru
Araki, Kazuhiro
Fujita, Ken-Ichi
Yamamoto, Wataru
Endo, Hisashi
Nagashima, Fumio
Tanaka, Ryuhei
Miya, Toshimichi
Kodama, Keiji
Sunakawa, Yu
Narabayashi, Masaru
Ando, Yuichi
Akiyama, Yuko
Kawara, Kaori
Sasaki, Yasutsuna
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
[12] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters -: Reply
Hoskins, Janelle M.
McLeod, Howard L.
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
[13] UGT1A1*28 genotype and irinotecan dose adaptation in patients with metastatic colorectal cancer (MCRC) - A dutch colorectal cancer group (DCCG) study
Kweekel, Dina M.
Gelderblom, Hans
van der Straaten, Tahar
Punt, Cornelis J.
Guchelaar, Henk-Jan
ANNALS OF ONCOLOGY, 2006, 17 : 257 - 257
[14] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
Fei-fei Han
Chang-long Guo
Dan Yu
Jin Zhu
Li-li Gong
Guang-run Li
Ya-li Lv
He Liu
Guang-yu An
Li-hong Liu
Cancer Chemotherapy and Pharmacology, 2014, 73 : 779 - 788
[15] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
Han, Fei-fei
Guo, Chang-long
Yu, Dan
Zhu, Jin
Gong, Li-li
Li, Guang-run
Lv, Ya-li
Liu, He
An, Guang-yu
Liu, Li-hong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 779 - 788
[16] The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis
Chen, Yi-Jing
Hu, Fei
Li, Chun-Yan
Fang, Jue-Min
Chu, Li
Zhang, Xi
Xu, Qing
BIOMARKERS, 2014, 19 (01) : 56 - 62
[17] Evaluation of severe neutropenia and diarrhea in Asian cancer patients receiving UGT1A1 genotype-guided irinotecan dosing.
Sutiman, Natalia
Ramasamy, Saminathan
Ng, Chau Hsien Matthew
Choo, SuPin
Wenrui, Rachel Lim
Ling, Clarinda Chua Wei
Kuang, John Chia Whay
Tan, Iain B.
Chowbay, Balram
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[18] Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype
Rauchschwalbe, SK
Zühlsdorf, MT
Wensing, G
Kuhlmann, J
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (02) : 73 - 77
[19] A genotype-directed study to optimize dosing of irinotecan according to the UGT1A1 genotype.
Innocenti, Federico
Salgia, Ravi
Ramirez, Jacqueline
Janisch, Linda A.
Undevia, Samir D.
House, Larry
Das, Soma
Wu, Kehua
Turcich, Michelle
Marsh, Robert de Wilton
Karrison, Theodore
Maitland, Michael L.
Schilsky, Richard L.
Ratain, Mark J.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[20] Clinical Implications of UGT1A1*28 Genotype Testing in Colorectal Cancer Patients
Shulman, Katerina
Cohen, Ilana
Barnett-Griness, Ofra
Kuten, Abraham
Gruber, Stephen B.
Lejbkowicz, Flavio
Rennert, Gad
CANCER, 2011, 117 (14) : 3156 - 3162

← 1 2 3 4 5 →